160 related articles for article (PubMed ID: 1486156)
21. Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.
Hunt JN; Franz DR
Dig Dis Sci; 1981 Apr; 26(4):301-5. PubMed ID: 6972294
[TBL] [Abstract][Full Text] [Related]
22. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
[TBL] [Abstract][Full Text] [Related]
23. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy.
Berkowitz JM; Rogenes PR; Sharp JT; Warner CW
Arch Intern Med; 1987 Dec; 147(12):2137-9. PubMed ID: 3689065
[TBL] [Abstract][Full Text] [Related]
24. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
25. Abolition by omeprazole of aspirin induced gastric mucosal injury in man.
Daneshmend TK; Stein AG; Bhaskar NK; Hawkey CJ
Gut; 1990 May; 31(5):514-7. PubMed ID: 2190865
[TBL] [Abstract][Full Text] [Related]
26. Effects of ranitidine for exercise induced gastric mucosal changes and bleeding.
Choi SJ; Kim YS; Chae JR; Cho HK; Kim TH; Sohn YW; Oh YL; Seo GS; Nah YH; Choi SC
World J Gastroenterol; 2006 Apr; 12(16):2579-83. PubMed ID: 16688805
[TBL] [Abstract][Full Text] [Related]
27. Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans.
Konturek PC; Konturek SJ; Celinski K; Slomka M; Cichoz-Lach H; Bielanski W; Reiter RJ
J Pineal Res; 2010 May; 48(4):318-23. PubMed ID: 20443220
[TBL] [Abstract][Full Text] [Related]
28. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
29. Effect of deglycyrrhizinated liquorice on gastric mucosal damage by aspirin.
Rees WD; Rhodes J; Wright JE; Stamford LF; Bennett A
Scand J Gastroenterol; 1979; 14(5):605-7. PubMed ID: 493863
[TBL] [Abstract][Full Text] [Related]
30. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of health volunteers.
Lanza FL; Nelson RS; Rack MF
J Clin Pharmacol; 1984; 24(2-3):89-95. PubMed ID: 6715565
[TBL] [Abstract][Full Text] [Related]
31. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man.
Moore JG; Goo RH
Chronobiol Int; 1987; 4(1):111-6. PubMed ID: 3677213
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
Sartori S; Trevisani L; Nielsen I; Tassinari D; Panzini I; Abbasciano V
J Clin Oncol; 2000 Feb; 18(3):463-7. PubMed ID: 10653861
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
Tozawa K; Oshima T; Okugawa T; Ogawa T; Ohda Y; Tomita T; Hida N; Fukui H; Hori K; Watari J; Nakamura S; Miwa H
Dig Dis Sci; 2014 Aug; 59(8):1885-90. PubMed ID: 24659236
[TBL] [Abstract][Full Text] [Related]
34. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
35. Omeprazole ameliorates aspirin-induced gastroduodenal injury.
Scheiman JM; Behler EM; Loeffler KM; Elta GH
Dig Dis Sci; 1994 Jan; 39(1):97-103. PubMed ID: 8281875
[TBL] [Abstract][Full Text] [Related]
36. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.
Robinson MG; Griffin JW; Bowers J; Kogan FJ; Kogut DG; Lanza FL; Warner CW
Dig Dis Sci; 1989 Mar; 34(3):424-8. PubMed ID: 2646087
[TBL] [Abstract][Full Text] [Related]
37. The role of acid in the pathogenesis of aspirin-induced gastrointestinal erosions and hemorrhage.
Cooke AR
Am J Dig Dis; 1973 Mar; 18(3):225-37. PubMed ID: 4571743
[No Abstract] [Full Text] [Related]
38. [Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects].
Müller P; Dammann HG; Bergdolt H; Simon B
Arzneimittelforschung; 1991 Jun; 41(6):638-9. PubMed ID: 1930353
[TBL] [Abstract][Full Text] [Related]
39. Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor.
Konturek SJ; Konturek JW; Kwiecien N; Obtułowicz W; Oleksy J; Hebzda Z; Amon I
Scand J Gastroenterol; 1991 Mar; 26(3):231-6. PubMed ID: 1853145
[TBL] [Abstract][Full Text] [Related]
40. Chronic beta-carotene supplementation does not alter the gastric mucosal response to acute aspirin ingestion.
Moses FM; Kikendall JW; Bowen P; Young TR
J Clin Gastroenterol; 1990 Jun; 12(3):267-70. PubMed ID: 2362094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
